Otonomy Provides Update on Clinical Trials and Development Programs

Back to Jobs

Results from Phase 3 trial of OTIVIDEX ® in Ménière’s disease expected in first quarter of 2021 Results from Phase 1/2 trial of OTO-313 in tinnitus expected in July 2020 Results from Phase 1/2 trial of OTO-413 in hearing loss expected in fourth quarter of 2020 Current capital funds operations

Apply Now